Figure 1. The down-regulation of miR-630 in HCC is associated with metastasis and poor clinical outcomes.

A. The expression of miR-630 in 97 liver tumors was quantified using RT-PCR. P-values correspond to the comparison of miR-630 expression between metastatic and non-metastatic HCC tissues and statistically significant differences are denoted by a P<0.05. B. Expression of miR-630 in incompletely encapsulated HCC tumors is lower than that of completely encapsulated tumors. C. Edmondson-Steiner tumor grades I-II and III-IV D. TNM stage I-II and III-IV E. BCLC stage 0+A and B+C F. Kaplan–Meier curves of the relationship between miR-630 expression and disease-free and overall survival.